Fund HoldingsSpringhill Fund Asset Management (HK) Co Ltd

Total Portfolio Value
$20.87M
Total Bought
$12.72M
Total Sold
$53.43M
Net Transaction
-$40.71M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
SUMMIT THERAPEUTICS INC(SMMT)0124,307+124,30702,39811.49%+2,398
REGENERON PHARMACEUTICALS(REGN)02,600+2,60001,6497.90%+1,649
NEUROCRINE BIOSCIENCES INC(NBIX)013,612+13,61201,5057.21%+1,505
SOLENO THERAPEUTICS INC1,79319,858+18,065811,4196.80%+1,338
JAZZ PHARMACEUTICALS PLC(JAZZ)09,853+9,85301,2235.86%+1,223
ARGENX SE(ARGX)01,146+1,14606783.25%+678
ELI LILLY & CO(LLY)0816+81606743.23%+674
PROTAGONIST THERAPEUTICS INC012,859+12,85906222.98%+622
JANUX THERAPEUTICS INC(JANX)29,60078,500+48,9001,5852,12010.16%+535
TG THERAPEUTICS INC(TGTX)013,500+13,50005322.55%+532
TARSUS PHARMACEUTICALS INC(TARS)07,076+7,07603631.74%+363
ASCENDIS PHARMA A/S(ASND)02,173+2,17303391.62%+339
RHYTHM PHARMACEUTICALS INC(RYTM)06,277+6,27703321.59%+332
BIONTECH SE(BNTX)03,000+3,00002731.31%+273
SPRINGWORKS THERAPEUTICS INC05,897+5,89702601.25%+260
ABIVAX SA(ABVX)207,6000-207,6001,5200-1,520
BICYCLE THERAPEUTICS PLC116,4000-116,4001,6300-1,630
BRIGHT MINDS BIOSCIENCES INC60,6480-60,6482,1850-2,185
VERONA PHARMA PLC135,45263,499-71,9536,2904,03219.32%-2,259
NURIX THERAPEUTICS INC(NRIX)160,5000-160,5003,0240-3,024
DYNE THERAPEUTICS INC(DYN)131,2000-131,2003,0910-3,091
INSMED INC(INSM)69,50019,192-50,3084,7981,4647.02%-3,334
CULLINAN THERAPEUTICS INC(CGEM)276,4000-276,4003,3670-3,367
AKERO THERAPEUTICS INC151,20019,925-131,2754,2068073.87%-3,400
MERUS N V83,8000-83,8003,5240-3,524
COGENT BIOSCIENCES INC(COGT)548,55429,491-519,0634,2791770.85%-4,102
VERA THERAPEUTICS INC(VERA)109,4000-109,4004,6270-4,627
ASTRAZENECA PLC(AZN)76,5000-76,5005,0120-5,012
CYTOKINETICS INC(CYTK)130,7350-130,7356,1500-6,150
LEGEND BIOTECH CORP(LEGN)190,8000-190,8006,2090-6,209
Page 1 of 1